A reappraisal of the MECT1/MAML2 translocation in salivary mucoepidermoid carcinomas

American Journal of Surgical Pathology

Volumn 34, Issue 8, 2010, Pages 1106-1121

  Seethala, Raja R ^a   Dacic, Sanja ^a   Cieply, Kathleen ^a   Kelly, Lindsey M ^a   Nikiforova, Marina N ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

adenosquamous; FISH; grade; MECT1 MAML2; mucoepidermoid carcinoma; prognosis; RT PCR

Indexed keywords

MECT1 MAML2 FUSION PROTEIN, HUMAN; MECT1-MAML2 FUSION PROTEIN, HUMAN; ONCOPROTEIN;

ADENOSQUAMOUS CARCINOMA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER STAGING; CHI SQUARE DISTRIBUTION; CHILD; DISEASE FREE SURVIVAL; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE EXPRESSION REGULATION; GENE TRANSLOCATION; GENETICS; HUMAN; KAPLAN MEIER METHOD; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND TUMOR; TIME;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, MUCOEPIDERMOID; CHI-SQUARE DISTRIBUTION; CHILD; DISEASE-FREE SURVIVAL; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; ONCOGENE PROTEINS, FUSION; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SALIVARY GLAND NEOPLASMS; TIME FACTORS; TRANSLOCATION, GENETIC; YOUNG ADULT;

EID: 77955176786     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3181de3021     Document Type: Article

References (35)

1. AJCC Cancer Staging Manual. Springer; 2010.
2. Achcar Rde O, Nikiforova MN, Dacic S, et al. Mammalian mastermind like 2 11q21 gene rearrangement in bronchopulmonary mucoepidermoid carcinoma. Hum Pathol. 2009;40:854-860.
3. Alos L, Castillo M, Nadal A, et al. Adenosquamous carcinoma of the head and neck: criteria for diagnosis in a study of 12 cases. Histopathology. 2004;44:570-579.
4. Alves FA, Pires FR, De Almeida OP, et al. PCNA, Ki-67 and p53 expressions in submandibular salivary gland tumours. Int J Oral Maxillofac Surg. 2004;33:593-597.
5. Anzick SL, Chen WD, Park Y, et al. Unfavorable prognosis of CRTC1-MAML2 positive mucoepidermoid tumors with CDKN2A deletions. Genes Chromosomes Cancer. 2010;49:59-69.
6. Auclair PL, Ellis GL. Mucoepidermoid carcinoma. In: Ellis GL, Auclair PL, Gnepp DR, eds. Surgical Pathology of the Salivary Glands. Philadelphia: Saunders; 1991:269-298.
7. Auclair PL, Goode RK, Ellis GL. Mucoepidermoid carcinoma of intraoral salivary glands. Evaluation and application of grading criteria in 143 cases. Cancer. 1992;69:2021-2030.
8. Behboudi A, Enlund F, Winnes M, et al. Molecular classification of mucoepidermoid carcinomas-prognostic significance of the MECT1-MAML2 fusion oncogene. Genes Chromosomes Cancer. 2006;45: 470-481.
9. Brandwein MS, Ivanov K, Wallace DI, et al. Mucoepidermoid carcinoma: a clinicopathologic study of 80 patients with special reference to histological grading. Am J Surg Pathol. 2001;25: 835-845.
10. Coxon A, Rozenblum E, Park YS, et al. Mect1-Maml2 fusion oncogene linked to the aberrant activation of cyclic AMP/CREB regulated genes. Cancer Res. 2005;65:7137-7144.
11. Damiani JM, Damiani KK, Hauck K, et al. Mucoepidermoid-adenosquamous carcinoma of the larynx and hypopharynx: a report of 21 cases and a review of the literature. Otolaryngol Head Neck Surg. 1981;89:235-243.
12. Evans HL. Mucoepidermoid carcinoma of salivary glands: a study of 69 cases with special attention to histologic grading. American J Clinical Pathol. 1984;81:696-701.
13. Fehr A, Roser K, Belge G, et al. A closer look at Warthin tumors and the t(11;19). Cancer Genet Cytogenet. 2008;180:135-139.
14. Fehr A, Roser K, Heidorn K, et al. A new type of MAML2 fusion in mucoepidermoid carcinoma. Genes Chromosomes Cancer. 2008; 47:203-206.
15. Gerughty RM, Hennigar GR, Brown FM. Adenosquamous carcinoma of the nasal, oral and laryngeal cavities. A clinicopatho-logic survey of ten cases. Cancer. 1968;22:1140-1155.
16. Goode R, El-Nagger A. Mucoepidermoid carcinoma. In: Barnes L, Eveson J, Reichart P, et al, eds. Pathology and Genetics Head and Neck Tumors. Lyon: IARC Press; 2005:219-220.
17. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82: 1217-1224.
18. Kapadia SB, Barnes L, Pelzman K, et al. Carcinoma ex oncocytic Schneiderian (cylindrical cell) papilloma. Am J Otolaryngol. 1993;14: 332-338.
19. Keelawat S, Liu CZ, Roehm PC, et al. Adenosquamous carcinoma of the upper aerodigestive tract: a clinicopathologic study of 12 cases and review of the literature. Am J Otolaryngol. 2002;23: 160-168.
20. Kiyoshima T, Shima K, Kobayashi I, et al. Expression of p53 tumor suppressor gene in adenoid cystic and mucoepidermoid carcinomas of the salivary glands. Oral Oncol. 2001;37:315-322.
21. Martins C, Cavaco B, Tonon G, et al. A study of MECT1-MAML2 in mucoepidermoid carcinoma and Warthin's tumor of salivary glands. J Mol Diagn. 2004;6:205-210.
22. Miyabe S, Okabe M, Nagatsuka H, et al. Prognostic significance of p27Kip1, Ki-67, and CRTC1-MAML2 fusion transcript in mucoe-pidermoid carcinoma: a molecular and clinicopathologic study of 101 cases. J Oral Maxillofac Surg. 2009;67:1432-1441.
23. Mutoh H, Nagata H, Ohno K, et al. Analysis of the p53 gene in parotid gland cancers: a relatively high frequency of mutations in low-grade mucoepidermoid carcinomas. Int J Oncol. 2001;18: 781-786.
24. Myers EN, Ferris RL, eds. Salivary Gland Disorders. Berlin: Springer; 2007.
25. Nakayama T, Miyabe S, Okabe M, et al. Clinicopathological significance of the CRTC3-MAML2 fusion transcript in mucoepi-dermoid carcinoma. Mod Pathol. 2009;22:1575-1581.
26. Nikiforov YE, Steward DL, Robinson-Smith TM, et al. Molecular testing for mutations in improving the fine-needle aspiration diagnosis of thyroid nodules. J Clin Endocrinol Metab. 2009;94: 2092-2098.
27. Nikiforova MN, Caudill CM, Biddinger P, et al. Prevalence of RET/PTC rearrangements in Hashimoto's thyroiditis and papillary thyroid carcinomas. Int J Surg Pathol. 2002;10:15-22.
28. Nordkvist A, Gustafsson H, Juberg-Ode M, et al. Recurrent rearrangements of 11q14-22 in mucoepidermoid carcinoma. Cancer Genet Cytogenet. 1994;74:77-83.
29. Okabe M, Inagaki H, Murase T, et al. Prognostic significance of p27 and Ki-67 expression in mucoepidermoid carcinoma of the intraoral minor salivary gland. Mod Pathol. 2001;14:1008-1014.
30. Okabe M, Miyabe S, Nagatsuka H, et al. MECT1-MAML2 fusion transcript defines a favorable subset of mucoepidermoid carcinoma. Clin Cancer Res. 2006;12:3902-3907.
31. Seethala R. An update on grading of salivary gland carcinomas. Head Neck Pathol. 2009;3:69-77.
32. Seethala RR, Hoschar AP, Bennett A, et al. Reproducibility of grading in salivary gland mucoepidermoid carcinoma and correlation with outcome: does system really matter? Mod Pathol. 2008;21: 241A.
33. Skalova A, Lehtonen H, von Boguslawsky K, et al. Prognostic significance of cell proliferation in mucoepidermoid carcinomas of the salivary gland: clinicopathological study using MIB 1 antibody in paraffin sections. Hum Pathol. 1994;25:929-935. (Pubitemid 24292411)
34. Tirado Y, Williams MD, Hanna EY, et al. CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: implications for histogenesis and biologic behavior. Genes Chromosomes Cancer. 2007;46: 708-715.
35. Tonon G, Modi S, Wu L, et al. t(11;19)(q21;p13) translocation in mucoepidermoid carcinoma creates a novel fusion product that disrupts a Notch signaling pathway. Nat Genet. 2003;33:208-213.